Mechanism of Qingdai in Alleviating Acute Lung Injury by Inhibiting the JAK2/STAT3 Signaling Pathway

Lu Qi,1– 3,* Shun Wang,1,3,* Tao Guo,1,3 Zhuocao Qi,1,3 Suwan Wu,1,3 Dan Gao,1,3 Zhiqiang Yan,4 Bo Tan,4 Aidong Yang1,3 1The Research Center for Traditional Chinese Medicine, Shanghai Institute of Infectious Diseases and Biosecurity, Shanghai University of Traditional Chinese Medicin...

Full description

Saved in:
Bibliographic Details
Main Authors: Qi L, Wang S, Guo T, Qi Z, Wu S, Gao D, Yan Z, Tan B, Yang A
Format: Article
Language:English
Published: Dove Medical Press 2024-12-01
Series:Journal of Inflammation Research
Subjects:
Online Access:https://www.dovepress.com/mechanism-of-qingdai-in-alleviating-acute-lung-injury-by-inhibiting-th-peer-reviewed-fulltext-article-JIR
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850244478992908288
author Qi L
Wang S
Guo T
Qi Z
Wu S
Gao D
Yan Z
Tan B
Yang A
author_facet Qi L
Wang S
Guo T
Qi Z
Wu S
Gao D
Yan Z
Tan B
Yang A
author_sort Qi L
collection DOAJ
description Lu Qi,1– 3,* Shun Wang,1,3,* Tao Guo,1,3 Zhuocao Qi,1,3 Suwan Wu,1,3 Dan Gao,1,3 Zhiqiang Yan,4 Bo Tan,4 Aidong Yang1,3 1The Research Center for Traditional Chinese Medicine, Shanghai Institute of Infectious Diseases and Biosecurity, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China; 2The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People’s Hospital, Yichang, 443003, People’s Republic of China; 3School of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China; 4Laboratory of Clinical Pharmacokinetics, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China*These authors contributed equally to this workCorrespondence: Aidong Yang; Bo Tan, Email aidongy@126.com; tbot@163.comObjective: Qingdai (QD) is a traditional Chinese medicine (TCM) commonly used in clinical practice to treat acute lung injury/acute respiratory distress syndrome (ALI/ARDS). However, the mechanisms underlying the effects of QD remain not fully understood. This investigation demonstrated QD alleviated LPS-induced ALI in mice and exerted anti-inflammatory effects by inhibiting the JAK2/STAT3 signaling pathway.Methods: The active compounds of QD were identified through UPLC-LTQ-Orbitrap-MS/MS. Network pharmacology predicted potential pharmacological targets and the signaling pathways contributed to the effectiveness of QD in treating ALI. Molecular docking assessed the binding of active components to critical targets. ALI mice triggered by Lipopolysaccharides (LPS) were used for transcriptomic analysis to assess alterations in pulmonary gene expression. The pathological changes of lung tissue were analyzed via HE staining. Proinflammatory cytokine levels in serum were measured using ELISA, and the mRNA expression was measured by RT-qPCR. Western blot analysis evaluated protein expression related to the JAK2/STAT3 signaling pathway. Additionally, RAW264.7 cells induced by LPS were treated with QD to measure proinflammatory cytokines and JAK2/STAT3 signaling pathway protein expression.Results: Six major components of QD were identified. Network pharmacology predicted JAK2 and STAT3 as targets for QD in ALI treatment, with KEGG analysis highlighting the JAK/STAT signaling pathway. Transcriptomics confirmed the JAK/STAT signaling pathway in the therapeutic effects of QD. Molecular docking demonstrated high binding affinities of bisindigotin, isoindigo, and 6-(3-oxoindolin-2-ylidene)indolo[2,1-b]quinazolin-12-one (IQO) to JAK2 and STAT3. In vivo, QD reduced lung inflammation, downregulated proinflammatory cytokines, and inhibited JAK2/STAT3 signaling pathway. In vitro, QD mitigated LPS-triggered inflammatory responses in RAW264.7 macrophages by inhibiting the same pathway.Conclusion: The therapeutic effects of QD in ALI might be mediated by the modulation of the JAK2/STAT3 signaling pathway, which may make it a valuable therapeutic strategy for ALI/ARDS. Keywords: Qingdai, acute lung injury, anti-inflammation, macrophages, JAK2/STAT3
format Article
id doaj-art-7fc18bee43e645d18fde6dac8acb9841
institution OA Journals
issn 1178-7031
language English
publishDate 2024-12-01
publisher Dove Medical Press
record_format Article
series Journal of Inflammation Research
spelling doaj-art-7fc18bee43e645d18fde6dac8acb98412025-08-20T01:59:43ZengDove Medical PressJournal of Inflammation Research1178-70312024-12-01Volume 17114031141798613Mechanism of Qingdai in Alleviating Acute Lung Injury by Inhibiting the JAK2/STAT3 Signaling PathwayQi LWang SGuo TQi ZWu SGao DYan ZTan BYang ALu Qi,1– 3,* Shun Wang,1,3,* Tao Guo,1,3 Zhuocao Qi,1,3 Suwan Wu,1,3 Dan Gao,1,3 Zhiqiang Yan,4 Bo Tan,4 Aidong Yang1,3 1The Research Center for Traditional Chinese Medicine, Shanghai Institute of Infectious Diseases and Biosecurity, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China; 2The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People’s Hospital, Yichang, 443003, People’s Republic of China; 3School of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China; 4Laboratory of Clinical Pharmacokinetics, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China*These authors contributed equally to this workCorrespondence: Aidong Yang; Bo Tan, Email aidongy@126.com; tbot@163.comObjective: Qingdai (QD) is a traditional Chinese medicine (TCM) commonly used in clinical practice to treat acute lung injury/acute respiratory distress syndrome (ALI/ARDS). However, the mechanisms underlying the effects of QD remain not fully understood. This investigation demonstrated QD alleviated LPS-induced ALI in mice and exerted anti-inflammatory effects by inhibiting the JAK2/STAT3 signaling pathway.Methods: The active compounds of QD were identified through UPLC-LTQ-Orbitrap-MS/MS. Network pharmacology predicted potential pharmacological targets and the signaling pathways contributed to the effectiveness of QD in treating ALI. Molecular docking assessed the binding of active components to critical targets. ALI mice triggered by Lipopolysaccharides (LPS) were used for transcriptomic analysis to assess alterations in pulmonary gene expression. The pathological changes of lung tissue were analyzed via HE staining. Proinflammatory cytokine levels in serum were measured using ELISA, and the mRNA expression was measured by RT-qPCR. Western blot analysis evaluated protein expression related to the JAK2/STAT3 signaling pathway. Additionally, RAW264.7 cells induced by LPS were treated with QD to measure proinflammatory cytokines and JAK2/STAT3 signaling pathway protein expression.Results: Six major components of QD were identified. Network pharmacology predicted JAK2 and STAT3 as targets for QD in ALI treatment, with KEGG analysis highlighting the JAK/STAT signaling pathway. Transcriptomics confirmed the JAK/STAT signaling pathway in the therapeutic effects of QD. Molecular docking demonstrated high binding affinities of bisindigotin, isoindigo, and 6-(3-oxoindolin-2-ylidene)indolo[2,1-b]quinazolin-12-one (IQO) to JAK2 and STAT3. In vivo, QD reduced lung inflammation, downregulated proinflammatory cytokines, and inhibited JAK2/STAT3 signaling pathway. In vitro, QD mitigated LPS-triggered inflammatory responses in RAW264.7 macrophages by inhibiting the same pathway.Conclusion: The therapeutic effects of QD in ALI might be mediated by the modulation of the JAK2/STAT3 signaling pathway, which may make it a valuable therapeutic strategy for ALI/ARDS. Keywords: Qingdai, acute lung injury, anti-inflammation, macrophages, JAK2/STAT3https://www.dovepress.com/mechanism-of-qingdai-in-alleviating-acute-lung-injury-by-inhibiting-th-peer-reviewed-fulltext-article-JIRqingdaiacute lung injuryanti-inflammationmacrophagesjak2/stat3
spellingShingle Qi L
Wang S
Guo T
Qi Z
Wu S
Gao D
Yan Z
Tan B
Yang A
Mechanism of Qingdai in Alleviating Acute Lung Injury by Inhibiting the JAK2/STAT3 Signaling Pathway
Journal of Inflammation Research
qingdai
acute lung injury
anti-inflammation
macrophages
jak2/stat3
title Mechanism of Qingdai in Alleviating Acute Lung Injury by Inhibiting the JAK2/STAT3 Signaling Pathway
title_full Mechanism of Qingdai in Alleviating Acute Lung Injury by Inhibiting the JAK2/STAT3 Signaling Pathway
title_fullStr Mechanism of Qingdai in Alleviating Acute Lung Injury by Inhibiting the JAK2/STAT3 Signaling Pathway
title_full_unstemmed Mechanism of Qingdai in Alleviating Acute Lung Injury by Inhibiting the JAK2/STAT3 Signaling Pathway
title_short Mechanism of Qingdai in Alleviating Acute Lung Injury by Inhibiting the JAK2/STAT3 Signaling Pathway
title_sort mechanism of qingdai in alleviating acute lung injury by inhibiting the jak2 stat3 signaling pathway
topic qingdai
acute lung injury
anti-inflammation
macrophages
jak2/stat3
url https://www.dovepress.com/mechanism-of-qingdai-in-alleviating-acute-lung-injury-by-inhibiting-th-peer-reviewed-fulltext-article-JIR
work_keys_str_mv AT qil mechanismofqingdaiinalleviatingacutelunginjurybyinhibitingthejak2stat3signalingpathway
AT wangs mechanismofqingdaiinalleviatingacutelunginjurybyinhibitingthejak2stat3signalingpathway
AT guot mechanismofqingdaiinalleviatingacutelunginjurybyinhibitingthejak2stat3signalingpathway
AT qiz mechanismofqingdaiinalleviatingacutelunginjurybyinhibitingthejak2stat3signalingpathway
AT wus mechanismofqingdaiinalleviatingacutelunginjurybyinhibitingthejak2stat3signalingpathway
AT gaod mechanismofqingdaiinalleviatingacutelunginjurybyinhibitingthejak2stat3signalingpathway
AT yanz mechanismofqingdaiinalleviatingacutelunginjurybyinhibitingthejak2stat3signalingpathway
AT tanb mechanismofqingdaiinalleviatingacutelunginjurybyinhibitingthejak2stat3signalingpathway
AT yanga mechanismofqingdaiinalleviatingacutelunginjurybyinhibitingthejak2stat3signalingpathway